Silexion Therapeutics Corp (SLXN)
(Delayed Data from NSDQ)
$9.28 USD
-5.66 (-37.88%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $9.28 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Silexion Therapeutics Corp has a market cap of $8.66M, which represents its share price of $14.94 multiplied by its outstanding shares number of 0.58M. As a small-cap company, SLXN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SLXN 9.28 -5.66(-37.88%)
Will SLXN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SLXN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for SLXN
Crude Oil Down 2%; Amazon Shares Tumble After Q2 Results
12 Health Care Stocks Moving In Friday's Intraday Session
Silexion Therapeutics (SLXN) Trading Activity Resumes
Silexion Therapeutics (SLXN) Trading Temporarily Halted Due to Volatility
Nasdaq Dips Over 2%; Apple Earnings Top Views